Capricor Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 137.86, 128.37, 351.35, 516.42, 708.9 ], "ebit_estimate": [ -29.63, -58.34, 125.34, 268.43, 411.7 ], "ebitda_estimate": [ -154.2, -168.7, null, null, null ], "net_income_estimate": [ -19.77, -46.84, 144.08, 237.46, 356.13 ], "per_share_eps_estimate": [ -0.1, -0.94, 2.11, 3.57, 5.51 ], "eps_nri_estimate": [ -0.4, -0.94, 1.53, 3.57, 5.51 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -45.02, -60.79, 126.82, 252.67, 379.71 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 84, 80, 82, 85, 85 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 10.18, 6.03, 3.9 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, 59.48, 78.44, 10.07, 15.43, 19.8, 25.17 ], "ebit_estimate": [ -35.01, 13.24, 53.68, -23.64, -20.36, -17.14, -13.88 ], "ebitda_estimate": [ -37.7, -39.9, -39.9, null, null, null, null ], "net_income_estimate": [ -34.59, 6.61, 42.26, -23.21, -20.06, -16.98, -13.85 ], "per_share_eps_estimate": [ -0.59, 0.45, 0.48, -0.4, -0.34, -0.29, -0.23 ], "eps_nri_estimate": [ -0.59, 0.09, 0.51, -0.4, -0.34, -0.29, -0.23 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -35.77, 19.2, 5.71, -26.8, -23.4, -20.11, -16.71 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 75, 45, null, null, 75, 75 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 109.69, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }